by Legal Desire

Lawyer profile

Chris Schott

Latham & Watkins LLP

Claim this profile

Firm: Latham & Watkins LLP
Practice: healthcare regulatory, regulatory
Office: Washington, D.C.
Active in the record: 2024 to 2025

Deal experience

Deal types

IP & Technology M&A

Sectors

Healthcare & Life Sciences

Jurisdictions

Australia Europe New Zealand United States

Deals

3 announced deals in the record

Latham Advises Norgine on Exclusive Licensing Agreement With Vir Biotechnology 18 Dec 2025

IP & Technology Healthcare & Life Sciences Latham & Watkins LLP EUR 55m regulatory Washington, D.C.

Latham & Watkins Advises Coherus BioSciences in US$558.4 Million Divesture of UDENYCA Franchise to Intas Pharmaceuticals 5 Dec 2024

M&A Healthcare & Life Sciences Latham & Watkins LLP USD 558m healthcare regulatory Washington, D.C.

Latham & Watkins Advises Coherus BioSciences in Divestment of Ophthalmology Franchise to Sandoz 22 Jan 2024

M&A Healthcare & Life Sciences Latham & Watkins LLP USD 170m healthcare regulatory Washington, D.C.

Deal alerts PRO

Get an email when Chris Schott is named on a newly announced deal.

Alerts come as one daily email at most.

Pro

Analytics for Chris Schott

The paid plans add analytics for this lawyer, and for every firm and lawyer in the database:

Complete deal history, filtered by keyword, deal type, sector and year
Deals by year, sector and deal type
Frequent co-counsel and the firms most often on the other side
Repeat clients, as named in the announcements
CSV and Excel export

SEE PLANS SIGN IN

Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction